Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer.

Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP.

J Clin Oncol. 2011 Jan 1;29(1):54-60. doi: 10.1200/JCO.2010.29.3183. Epub 2010 Nov 29.

2.

Prolonged Nightly Fasting and Breast Cancer Prognosis.

Marinac CR, Nelson SH, Breen CI, Hartman SJ, Natarajan L, Pierce JP, Flatt SW, Sears DD, Patterson RE.

JAMA Oncol. 2016 Aug 1;2(8):1049-55. doi: 10.1001/jamaoncol.2016.0164.

PMID:
27032109
3.

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.

Andersson C, van Gaal L, Caterson ID, Weeke P, James WP, Coutinho W, Finer N, Sharma AM, Maggioni AP, Torp-Pedersen C.

Diabetologia. 2012 Sep;55(9):2348-55. doi: 10.1007/s00125-012-2584-3. Epub 2012 May 26. Erratum in: Diabetologia. 2012 Oct;55(10):2860. Couthino, W [corrected to Coutinho, W].

PMID:
22638548
4.

Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.

Cardoso CR, Leite NC, Ferreira MT, Salles GF.

Acta Diabetol. 2015 Feb;52(1):21-9. doi: 10.1007/s00592-014-0592-0. Epub 2014 May 10.

PMID:
24816865
5.

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.

Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N.

Ann Intern Med. 2004 Sep 21;141(6):413-20.

PMID:
15381514
6.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
7.

Association between hemoglobin A1c and all-cause mortality: results of the mortality follow-up of the German National Health Interview and Examination Survey 1998.

Paprott R, Schaffrath Rosario A, Busch MA, Du Y, Thiele S, Scheidt-Nave C, Heidemann C.

Diabetes Care. 2015 Feb;38(2):249-56. doi: 10.2337/dc14-1787. Epub 2014 Nov 20.

PMID:
25414153
8.

Body weight correlates with mortality in early-stage breast cancer.

Enger SM, Greif JM, Polikoff J, Press M.

Arch Surg. 2004 Sep;139(9):954-58; discussion 958-60.

PMID:
15381612
9.

The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes.

Kirkman MS, McCarren M, Shah J, Duckworth W, Abraira C; VADT Study Group..

J Diabetes Complications. 2006 Mar-Apr;20(2):75-80.

PMID:
16504835
10.

Utility of hemoglobin A1c in predicting diabetes risk.

Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ.

J Gen Intern Med. 2004 Dec;19(12):1175-80.

11.

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2..

J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.

PMID:
14583175
12.

Glycemic control patterns and kidney disease progression among primary care patients with diabetes mellitus.

Cummings DM, Larsen LC, Doherty L, Lea CS, Holbert D.

J Am Board Fam Med. 2011 Jul-Aug;24(4):391-8. doi: 10.3122/jabfm.2011.04.100186.

13.

Obesity and outcomes in premenopausal and postmenopausal breast cancer.

Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1686-91.

14.

Plasma carotenoids and recurrence-free survival in women with a history of breast cancer.

Rock CL, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Newman VA, Hollenbach KA, Jones L, Caan BJ, Pierce JP.

J Clin Oncol. 2005 Sep 20;23(27):6631-8.

PMID:
16170170
15.

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.

16.

Long-term prognostic role of functional limitations among women with breast cancer.

Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A, Melisko M, Esserman L, Weltzien EK, Caan BJ.

J Natl Cancer Inst. 2010 Oct 6;102(19):1468-77. doi: 10.1093/jnci/djq344. Epub 2010 Sep 22.

17.

Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes.

Egede LE, Mueller M, Echols CL, Gebregziabher M.

Med Care. 2010 Jun;48(6):527-33. doi: 10.1097/MLR.0b013e3181d558dc.

PMID:
20473215
18.

Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.

Hou G, Zhang S, Zhang X, Wang P, Hao X, Zhang J.

Breast Cancer Res Treat. 2013 Feb;137(3):807-16. doi: 10.1007/s10549-012-2404-y. Epub 2013 Jan 6.

PMID:
23292119
19.

Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity.

Perna M, Romagnuolo J, Morgan K, Byrne TK, Baker M.

Surg Obes Relat Dis. 2012 Nov-Dec;8(6):685-90. doi: 10.1016/j.soard.2011.08.002. Epub 2011 Aug 10.

PMID:
21982941
20.

[Albuminuria in patients with type 2 diabetes mellitus in relation to percentage of HbA1c].

KamiƄska J, Koper OM, Czyzewska J, Wasilewska K, Kemona H.

Pol Merkur Lekarski. 2012 May;32(191):302-5. Polish.

PMID:
22779336

Supplemental Content

Support Center